Job Description
We are currently recruiting two highly motivated Research Scientists to join the Targeted Radiopharmaceuticals team developing theranostics for the treatment of cancer.
The research scientists will play a key role supporting our preclinical imaging strategy performing PET /SPECT/μCT, MRI and Optical Imaging studies, biomedical image data processing, preparation and QC of radiolabelled drug products.
These laboratory-based positions offer an exciting opportunity to be part of a dynamic team developing new theranostic approaches in targeted alpha therapy for the treatment of cancer.
We are looking for either PhD level scientists, or MSc level graduates with relevant experience.
**Examples of responsibilities**
- Ensure a safe and compliant laboratory environment
- Animal handling, administration of drug product and operation of a diverse park of preclinical imaging systems
- Perform quantitative analysis of imaging data using state-of-the-art software tools, extracti...
The research scientists will play a key role supporting our preclinical imaging strategy performing PET /SPECT/μCT, MRI and Optical Imaging studies, biomedical image data processing, preparation and QC of radiolabelled drug products.
These laboratory-based positions offer an exciting opportunity to be part of a dynamic team developing new theranostic approaches in targeted alpha therapy for the treatment of cancer.
We are looking for either PhD level scientists, or MSc level graduates with relevant experience.
**Examples of responsibilities**
- Ensure a safe and compliant laboratory environment
- Animal handling, administration of drug product and operation of a diverse park of preclinical imaging systems
- Perform quantitative analysis of imaging data using state-of-the-art software tools, extracti...
Ready to Apply?
Submit your application today and join our talented team at Bayer Nordic.
Submit ApplicationJob Details
- Location oslo, oslo
- Job Type Full-time
- Category Other-General
- Posted Date June 10, 2026
- Application Deadline July 20, 2026